QDEL

Quidel Receives CE Mark for Savanna® Multiplex Molecular Analyzer and Respiratory Viral Panel

Quidel Recalls Lyra COVID Diagnostic Test Due To Potential False Negative Results

Why Quidel Shot 4% Higher Today

Quidel: Primed For Acquisitions

With Lyme Disease on the Rise Nationwide, Quidel Corporation Urges Early Testing With Its Rapid Point-of-Care Test

3 Stocks Wall Street Thinks Will Skyrocket 50% or More